Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Genmont Probiotic on blood glucose and other diabetes-related parameters in adults with Type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genmont Probiotic (probiotic)

Snippet

Sponsor: GenMont Biotech Incorporation | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED